Does RUXOLITINIB Cause Haematocrit increased? 347 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 347 reports of Haematocrit increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.5% of all adverse event reports for RUXOLITINIB.
347
Reports of Haematocrit increased with RUXOLITINIB
0.5%
of all RUXOLITINIB reports
5
Deaths
35
Hospitalizations
How Dangerous Is Haematocrit increased From RUXOLITINIB?
Of the 347 reports, 5 (1.4%) resulted in death, 35 (10.1%) required hospitalization, and 5 (1.4%) were considered life-threatening.
Is Haematocrit increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 347 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Haematocrit increased?
TESTOSTERONE (114)
CLOZAPINE (89)
ROPEGINTERFERON ALFA-2B-NJFT (74)
EMPAGLIFLOZIN (59)
ALEMTUZUMAB (51)
SOMATROPIN (46)
ROSUVASTATIN (44)
RAMIPRIL (42)
METHOTREXATE (35)
ADALIMUMAB (34)
Which RUXOLITINIB Alternatives Have Lower Haematocrit increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE